Bryan Johnson on Hyperbaric Oxygen Therapy and India's Air Pollution

Open on YouTube ↗
Overview

In this episode, Bryan Johnson, Blueprint co-founder Kate Tolo, and Johnson's lead physician Dr. Mike Mallin cover two topics that Tolo describes as opposites. The first is hyperbaric oxygen therapy (HBOT), which Johnson tested in a 60-session protocol and now calls possibly the most effective whole-body intervention Blueprint has tried. The second is the air pollution the team encountered on a trip to India, which Johnson says left him physically and emotionally overwhelmed. It became a national talking point after he walked off a podcast recording. The episode ends with practical advice on managing air quality and a broader argument for running health on systems rather than in-the-moment decisions.

17 min read

Why HBOT made the shortlist

Johnson explains that when Blueprint started, the team tried to set aside popular wellness trends such as cold plunges, NAD drips, and vitamin infusions. Instead, they asked what the scientific literature showed as the most robust ways to move markers that predict longevity. HBOT made that shortlist, but Johnson stresses that the evidence for HBOT as a longevity therapy is "not airtight" and still emerging. He points to a 2020 study out of Israel that brought attention to HBOT through telomere elongation. He adds that, as usual in science, it was not accepted as a panacea, and some researchers questioned whether the study was well done and robust.

So the team decided to test it on Johnson. Mallin designed a protocol using a 2 ATA chamber (two atmospheres absolute). Johnson did 60 sessions over 90 days, each lasting 90 minutes. Within each session, oxygen was delivered in cycles of 20 minutes on and 5 minutes off. Johnson describes the swing from high to low oxygen as what "creates nice signaling mechanisms within the body."

The reported results

Johnson read out the results and said the team was surprised. In his words, they would "probably say it has been the most efficacious therapy we have done since starting Blueprint for the entire body." He reported:

  • a 300% increase in VEGF, which he associates with new blood vessel growth;
  • hs-CRP, the systemic inflammation marker, falling to undetectable levels;
  • microbiome changes, including a 1,000% increase in Akkermansia, a 250% increase in short-chain fatty acids, and a 290% increase in butyrate;
  • a 28.6% reduction in a dementia marker;
  • improvements in muscle oxygenation.

A second company also analyzed his microbiome. Johnson says it used AI tools to draw on more than 200,000 microbiome papers and found no dysbiosis, meaning no disease signature. He says this put him in the top 10% of microbiomes sampled for that signature, which he called very rare.

On muscle oxygenation, Johnson said he still needs a VO2 max test on a lab-grade system to see what changed. He began to bring up a telomere measurement, then said he would pause and return to it. The episode never came back to it. Tolo's introduction had listed boosted telomeres among the results, but Johnson himself gives no telomere figures in the conversation.

Mallin said the inflammation and microbiome results impressed him most. For the microbiome, he called HBOT "the most impactful intervention I've ever seen." On inflammation, he noted that Johnson started from an already low baseline. Getting lower still in such a short time, with essentially no other intervention, struck him as "pretty insane."

"HBOT skin"

Johnson did not measure skin rejuvenation directly; there was no biopsy. He cited figures from several studies instead: a 12.8% increase in collagen density, a 144% increase in elastic fiber length, and a 41% increase in blood vessel count. Tolo notes that Johnson has started calling the effect "HBOT skin." She recounts meeting Ari Emanuel, CEO of WME, the week before. Johnson recognized "HBOT skin" on him, and Emanuel confirmed he loves HBOT.

Johnson says his son Talmage has also started doing HBOT at the house, and that he can see a signature in skin texture, color, and tone. He noticed it in himself first. Johnson's view is that HBOT is "probably the most significant skin glowup of any therapy out there." He ranks it above lasers or other machines, and above the usual starting points of fillers and Botox. His reasoning is that it works on the whole body rather than just part of the face. He presents this as his opinion, not a measured comparison.

The practical problem: time and access

Tolo asks how people can access HBOT when most cannot own a chamber, noting that LA has many places offering it. Johnson first names time as the obstacle. His protocol meant more than 70 hours in the chamber over 90 days. He says he could not have done it without working at the same time. His chamber lets him sit in a chair at a desk, take meetings, and write.

He explains that his chamber keeps the ambient oxygen at 21%, the normal atmospheric level, while he breathes 100% oxygen through a mask. Filling the chamber itself with 100% oxygen creates fire risk. Keeping the ambient air at 21% is what makes it safe to bring electronics inside. For people going to a facility, he estimates that driving there, doing the session, and returning takes at least two and a half to three hours.

What specs matter, according to Mallin

Mallin says the key variable is pressure: going "deep enough." He explains that the team talks about "diving," because pressure rises the deeper you go. For longevity purposes, he wants to be above 1.5 ATA and ideally at 2.0, the pressure used in the Israeli study. Reaching that requires a hard-shell chamber. He says soft-shell chambers typically top out around 1.3 to 1.5.

The second variable is 100% oxygen, delivered the right way. If high-concentration oxygen fills the ambient air, it exposes the skin and especially the eyes, and Mallin says that can cause cataracts. His preferred setup delivers oxygen through a mask that you also exhale through, so the excess oxygen is vented out of the chamber rather than lingering in the air.

He calls sitting versus lying down a personal preference, though sitting in a slightly larger chamber makes it easier to use a phone or work. On session length, Johnson says 90-minute sessions have advantages over 60-minute ones. He then qualifies this: some indications, such as recovery, respond well to 60 minutes, while the longevity benefits they are pursuing are "really in the 90-minute range." Mallin adds that medical indications for HBOT use different protocols and that their discussion concerns longevity only.

Mallin also describes a likely spectrum of benefit. Johnson started near the high end. Less HBOT probably still helps, and "probably some HBOT is better than no HBOT," but Mallin says the research can't yet quantify where the inflection point of maximum benefit lies. He believes Johnson is likely near maximum benefit now.

How HBOT works, and whether you can overdo it

When Tolo asks whether someone can do too much, Mallin explains the mechanism as he understands it. At high pressure, oxygen dissolves into the serum rather than only binding to red blood cells, delivering what he describes as roughly 15 times the usual oxygen to tissue. High oxygen, he says, is actually damaging, even over short periods. The benefit comes from the body upregulating its own defenses against that damage. Because the exposure is pulsed and brief, the upregulation outlasts the stimulus. This leaves regenerative activity that would not otherwise have happened. He frames this as a hormetic response to something that is, "quote unquote," bad for you.

For the same reason, he says, doing it all the time could theoretically cause too much oxidative damage and leave no room for recovery. That is why the protocol ran about five days a week with two days off. After finishing it, they have scaled back to pulsing sessions occasionally.

Checking what you're actually getting

Tolo raises Johnson's point that some facilities may not deliver the oxygen levels they advertise. Johnson describes their own discovery. Their system originally used an oxygen concentrator, and when they measured its output it was around 89–92% rather than the 100% they expected. They replaced it with medical-grade oxygen cylinders delivered by a local company and fed them through the mask. Johnson acknowledges he doesn't know of evidence comparing 89–92% with 100%, only that they chose 100%.

He then lists the variables to check if you want HBOT to be effective. First is chamber pressure: 1.2–1.4 versus 2.0. Next are oxygen purity and whether it comes through a mask or fills the chamber. He also warns about 100% oxygen in the chamber air. The last variables are session frequency and total number of sessions. He notes that one session a week is not as good as sessions close together. Some indications only need around 20 sessions; they did the full 60. His overall assessment is that their 60-in-90 protocol roughly matched the benefits reported in the literature and "maybe" exceeded them in some areas. Because they had taken baseline measurements against target areas chosen from a literature search, he says they got a "really dramatic before and after snapshot."

Going to India

The conversation then turns to India, which Tolo calls the opposite of HBOT. She says the team went in December and nearly canceled at the last minute because of pollution. She describes some levels as hundreds of times above recommended PM2.5 limits. She also recalls that Johnson and Mallin concluded from the literature that pollution may shorten lives more than cancer in India, so the country might gain more by addressing pollution than by pursuing something like cancer.

Johnson explains that the trip, alongside a stop in China, was meant to seed the "Don't Die" movement in those countries. Until then it had existed mainly among small groups in the US. Friends in India arranged a three-day blitz across two cities. It included about five podcasts, four media interviews, and three or four private events. The original route went through Delhi, but they dropped Delhi at the last minute because its air quality was so bad.

The team wanted to raise a health topic with the country, and air quality was on their radar. In the days before departure, Johnson looked at air-quality data and was so alarmed that he called Tolo to say they should probably cancel. He knew India's air was bad, "but like not to this level." His friend reassured him that the hotel had monitored air purifiers throughout, with readings on screens. On landing, Johnson says, it was "an entirely different world." Seeing numbers on a map was one thing, but he could smell and feel the pollution in his nose, lungs, and throat. And the hotel, it turned out, had no air quality controls or filters.

"Breathing death" and normalization

Johnson explains why PM2.5 matters. These particles are 2.5 micrometers, small enough to get past the nose and throat, deep into the lungs, into the bloodstream, and possibly into the brain. They carry toxins from industrial pollution, vehicle emissions, and smoke, which he lists as nitrogen oxides, sulfur dioxide, and carbon monoxide. He links them to lung disease, cardiovascular damage, and neurodegeneration. He repeats the claim that India would extend lifespan more by addressing air pollution than by solving all cancer.

What struck him most was the normalization. He says many of the people they met were unaware of the problem. They didn't check air quality daily, didn't have purifiers at home, and exercised outdoors. "The more people learn about it the scarier it is," he says, and the issue wasn't being discussed or addressed. He calls it a representation of a more systemic problem in which people are "literally breathing death" and have become so used to it that they no longer see it. Within a couple of days, he says, the topic blew up in India and made the covers of major publications.

Johnson describes the experience as emotionally stressful. He recalls PM2.5 averaging around 75 to 120 depending on the city, which he equates to about three to five cigarettes a day. For someone who tracks every calorie and every movement, he says, imagining himself effectively smoking daily was "incomprehensible" and extremely upsetting.

Walking off the podcast

On day three, the night before flying to China, Johnson left a podcast recording partway through. He says it was not staged. He had reached the end of his rope, and Tolo notes that he was breaking out in rashes and his eyes were affected. She says the whole team was "really feeling it." The setting looked indoor but was effectively outdoors: a marquee-style transparent wall with no real separation from the outside air, at around 125 PM2.5.

Johnson asked to stop early, stepped out, then came back and wrapped the recording so as not to be rude to the host. He assumed they would cut the moment and simply publish a shorter episode. Instead, the footage became what he calls the inflection point that got the whole country talking, and he says the conversation continues today.

America's version: obesity

Johnson and Tolo both stress that the point is not to single out India. Tolo draws the parallel: Indians are breathing death and normalized to it, while Americans are "eating death" and normalized to that. Johnson recounts landing at LAX after two weeks on the road and seeing obesity everywhere. He says the share of obese Americans is shocking, though he doesn't remember the exact figure, and that he is so used to it at home that he no longer notices. "Every country has their own thing," he says.

Tolo adds that in both cases individuals can't easily overcome systemic forces. She points to food deserts across America, poor access to high-quality food, and addictive marketing placed right in front of people.

Mallin's air quality protocol

Asked what listeners can do, Mallin first notes that poor air quality is not unique to India. In the US, wildfires in the West have been the main recent problem. He cites local readings in the 200s and 300s and smoke from California, Oregon, and Washington fires spreading across the northern part of the country. LA also has chronic smog from traffic. He argues that local governments and school systems use criteria that are too lax. Most advise against outdoor exercise only above 150, while Johnson was worried about sitting outside at 125.

His recommendations follow in order:

  1. Measure. Set up a home monitor such as IQAir, and use IQAir's network of other people's monitors to see outdoor conditions. Also track indoor readings to confirm your filtration is working.
  2. Fix indoor air first. Use an HVAC filter rated MERV 13 or higher, which catches PM2.5-sized particles. Ideally add carbon filters for the chemicals in smog. Standalone purifiers help too; he names Dyson, IQAir, and Molekule.
  3. Be selective about going outside. His own threshold is no outdoor exercise above a PM2.5 AQI of 100, while acknowledging that other sources may say differently. He personally rarely exercises outside above about 70, and he wears an N95 above 150.
  4. Consider supplements with a mechanistic rationale. For people facing a spike in exposure, such as travel or a local fire, he suggests compounds that manage reactive oxygen species, like N-acetylcysteine or glutathione, plus anti-inflammatories. His reasoning is that pollutants entering the lungs and bloodstream drive inflammation and reactive oxygen species. He links these to plaque development, damage to the blood–brain barrier, and brain inflammation.

Running health on systems

Johnson adds a point about avoiding overwhelm. He acknowledges his approach requires investment. His home keeps air quality steady around the clock, with monitoring in every room, IQAir purifiers, and two other purifiers he is currently testing, including a commercial-grade unit. He says MERV 13 is about the cap most home HVAC systems can handle, and many manufacturers recommend 11 or below, so the advice is to use the highest-rated filter your system tolerates. Once monitoring and filtration are in place, he says, "it's running without you thinking about it." He compares it to a fixed bedtime: identify the area, build a system, and put it on autopilot to reduce health stress.

He closes with an assignment for listeners. Write down your plan for the coming days: bedtime, exercise days and what you'll do, and commitments such as no fast food, no junk food, and cutting sugar. His reasoning is that people who decide in the moment are "very likely to cave," while a pre-committed plan gives them more strength when the moment arrives. He describes the episode as part of a new format the team has long wanted to try and asks viewers to say in the comments whether it's working and what they'd change.